EMA/PE/0000302950
Submitted by Anonymous (not verified) on 2 October 2026 - 14:27
EMA/PE/0000302950
Human medicines European public assessment report (EPAR): Rasilez, aliskiren, Date of authorisation: 22/08/2007, Revision: 29, Status: Authorised
Submitted by Anonymous (not verified) on 2 October 2026 - 14:25
Human medicines European public assessment report (EPAR): Rasilez, aliskiren, Date of authorisation: 22/08/2007, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Ordspono, odronextamab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 2 October 2026 - 14:01
Human medicines European public assessment report (EPAR): Ordspono, odronextamab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Sialanar, glycopyrronium bromide, Date of authorisation: 15/09/2016, Revision: 13, Status: Authorised
Submitted by Anonymous (not verified) on 2 October 2026 - 13:58
Human medicines European public assessment report (EPAR): Sialanar, glycopyrronium bromide, Date of authorisation: 15/09/2016, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 2 October 2026 - 13:28
Human medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 48, Status: Authorised
Submitted by Anonymous (not verified) on 2 October 2026 - 13:19
Human medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 48, Status: Authorised
Procedural timetables
Submitted by Anonymous (not verified) on 2 October 2026 - 13:05
Procedural timetables
Committee for Herbal Medicinal Products (HMPC): 6-8 July 2026, European Medicines Agency, Amsterdam, the Netherlands, from 6 July 2026 to 8 July 2026
Submitted by Anonymous (not verified) on 2 October 2026 - 12:51
Committee for Herbal Medicinal Products (HMPC): 6-8 July 2026, European Medicines Agency, Amsterdam, the Netherlands, from 6 July 2026 to 8 July 2026
Minutes of the HMPC meeting 6-8 July 2026
Submitted by Anonymous (not verified) on 2 October 2026 - 12:48
Minutes of the HMPC meeting 6-8 July 2026
List of centrally authorised products with safety-related changes to the product information
Submitted by Anonymous (not verified) on 2 October 2026 - 12:46
List of centrally authorised products with safety-related changes to the product information